Skip to content

Research at St Andrews

Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivo

Research output: Contribution to journalArticlepeer-review

Author(s)

K Morgan, Alan J. Stewart, NA Miller, Peter Mullen, M Muir, M Dodds, F Medda, David James Harrison, S Langdon, RP Millar

School/Research organisations

Abstract

Activation of gonadotropin-releasing hormone (GnRH) receptors inhibits proliferation of transformed cells derived from reproductive tissues and in transfected cell lines. Hence, GnRH receptors represent a therapeutic target for direct action of GnRH analogues on certain proliferating cells. However, more cell biological data are required to develop this particular application of GnRH analogues. Therefore, we compared the effects of GnRH receptor activation in transfected HEK293 cells (HEK293([SCL60])) with transfected human ovarian cancer cell lines SKOV3 and EFO21, human hepatoblastoma HepG2 cells, and rat neuroblastoma B35 cells. Marked differences in receptor levels, magnitude of inositol phosphate generation, and dynamics of inositol phosphate turnover occurred in the different cells. Activation of GnRH receptors, expressed at high or moderate levels, inhibited the growth of HEK293([SCL60]) and B35 cells, respectively. Western blotting detected markers of apoptosis [cleaved poly(ADP-ribose) polymerase, caspase-9] in HEK293([SCL60]) and B35 following treatment with 100 nmol/L d-Trp(6)-GnRH-I. Cell growth inhibition was partially or completely rescued with inhibitor Q-VD-OPh or Ro32-0432. Low levels of GnRH receptor expression in transfected SKOV3, EFO21, or HepG2 activated intracellular signaling but did not induce apoptosis or significantly affect cell proliferation. Tumor xenografts prepared from HEK293([SCL60]) regressed during treatment with d-Trp(6)-GnRH-I and growth of xenografts derived from transfected B35 was slowed. SKOV3 xenografts were not growth inhibited. Therefore, differences in levels of GnRH receptor and signaling differentially affect the apoptotic machinery within cell lines and contribute to the cell type-specific effects of GnRH on growth. Further studies should exploit the growth-inhibitory potential of GnRH receptor activation in abnormal cells in diseased human tissues.
Close

Details

Original languageEnglish
Pages (from-to)6331-6340
Number of pages10
JournalCancer Research
Volume68
Issue number15
DOIs
Publication statusPublished - 1 Aug 2008

    Research areas

  • Ovarian-cancer cells, Protein-kinase, Breast-cancer, Recombinant adenovirus, Growth-inhibition, Human endometrial, Gnrh receptor, HEK-293 cells, Expression, Carcinoma

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Genome-scale CRISPR/Cas9 screen determines factors modulating sensitivity to ProTide NUC-1031

    Sarr, A., Bré, J., Um, I. H., Chan, T. H., Mullen, P., Harrison, D. J. & Reynolds, P. A., 21 May 2019, In: Scientific Reports. 9, 13 p., 7643.

    Research output: Contribution to journalArticlepeer-review

  2. Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer

    Lubbock, A. L. R., Stewart, G. D., O'Mahoney, F. C., Laird, A., Mullen, P., O'Donnell, M., Powles, T., Harrison, D. J. & Overton, I. M., 26 Jun 2017, In: BMC Medicine. 15, 12 p., 118.

    Research output: Contribution to journalArticlepeer-review

  3. A signaling visualization toolkit to support rational design of combination therapies and biomarker discovery: SiViT

    Brown, J. L., Shovman, M., Robertson, P., Boiko, A., Goltsov, A., Mullen, P. & Harrison, D. J., May 2017, In: Oncotarget. 8, 18, p. 29657-29667 11 p.

    Research output: Contribution to journalArticlepeer-review

  4. Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells

    Meehan, J., Ward, C., Turnbull, A., Bukowski-Wills, J., Finch, A., Jarman, E. J., Xintaropoulou, C., Martinez-Perez, C., Gray, M., Pearson, M., Mullen, P., Supuran, C. T., Carta, F., Harrison, D. J., Kunkler, I. H. & Langdon, S., 2017, In: Oncotarget. 8, 26, p. 42857-42875

    Research output: Contribution to journalArticlepeer-review

  5. Total synthesis of dehaloperophoramidine using a highly diastereoselective Hosomi-Sakurai reaction

    Wilkie, R. P., Neal, A., Johnston, C. A., Voûte, N., Lancefield, C. S., Stell, M., Medda, F., Makiyi, E. F., Turner, E., Ojo, O. S., Slawin, A. M. Z., Lebl, T., Mullen, P., Harrison, D. J., Ireland, C. M. & Westwood, N. J., 14 Sep 2016, In: Chemical Communications. 52, 71, p. 10747-10750

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. Diagnostic accuracy of quantitative micro-elastography for margin assessment in breast-conserving surgery

    Kennedy, K. M., Zilkens, R., Allen, W. M., Foo, K. Y., Fang, Q., Chin, L., Sanderson, R. W., Anstie, J., Wijesinghe, P., Curatolo, A., Tan, H. E. I., Morin, N., Kunjuraman, B., Yeomans, C., Chin, S. L., DeJong, H., Giles, K., Dessauvagie, B. F., Latham, B., Saunders, C. M. & 1 others, Kennedy, B. F., Apr 2020, In: Cancer Research. 80, 8, p. 1773-1783 11 p.

    Research output: Contribution to journalArticlepeer-review

  2. The impact of early lapatinib-induced rash on disease-free and overall survival in patients treated within the ALTTO phase Ill randomized trial

    Azim, H. A., Sonnenblick, A., Agbor-Tarh, D., Bradbury, I., Daly, F., Huang, Y., Dueck, A. C., Pritchard, K., Wolff, A. C., Jackisch, C., Lang, I., Untch, M., Smith, I., Boyle, F., Xu, B., Gomez, H., Perez, E., Piccart, M. & de Azambuja, E., 15 Feb 2016, In: Cancer Research. 76, 2 p.

    Research output: Contribution to journalAbstractpeer-review

  3. Investigation of optical coherence microelastography as a method to visualize cancers in human breast tissue

    Kennedy, B. F., McLaughlin, R. A., Kennedy, K. M., Chin, L., Wijesinghe, P., Curatolo, A., Tien, A., Ronald, M., Latham, B., Saunders, C. M. & Sampson, D. D., 15 Aug 2015, In: Cancer Research. 75, 16, p. 3236-3245 10 p.

    Research output: Contribution to journalArticlepeer-review

  4. Correction: Physical oncology: A bench-to-bedside quantitative and predictive approach

    Frieboes, H. B., Chaplain, M. A. J., Thompson, A. M., Bearer, E. L., Lowengrub, J. S. & Cristini, V., 1 Mar 2011, In: Cancer Research. 71, 5, p. 2024 1 p.

    Research output: Contribution to journalArticlepeer-review

  5. Physical oncology: a bench-to-bedside quantitative and predictive approach

    Frieboes, H. B., Chaplain, M. A. J., Thompson, A. M., Bearer, E. L., Lowengrub, J. S. & Cristini, V., 15 Jan 2011, In: Cancer Research. 71, 2, p. 298-302 5 p.

    Research output: Contribution to journalArticlepeer-review

ID: 434175

Top